Bellevue Group Ag Ionis Pharmaceuticals Inc Transaction History
Bellevue Group Ag
- $4.39 Billion
- Q2 2025
A detailed history of Bellevue Group Ag transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bellevue Group Ag holds 7,853,198 shares of IONS stock, worth $323 Million. This represents 7.06% of its overall portfolio holdings.
Number of Shares
7,853,198
Previous 7,853,198
-0.0%
Holding current value
$323 Million
Previous $237 Million
30.96%
% of portfolio
7.06%
Previous 5.5%
Shares
32 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
149MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.7MShares$688 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$661 Million0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$516 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$425 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.35MShares$261 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.85B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...